Similarly, a CCL2 inhibitor, pirfenidone (PFD), was used to treat C57BL/6 J mouse bladder orthotopic tumor models, which resulted in a reduced tumor burden compared with that of the group given phosphate-buffered saline 19. The gene discussed is CCL2; the disease is neoplasm.